| 1.31 Delayed Data As of Jun 21 |  +0.025 / +1.95%Today’s Change | 1.02 Today|||52-Week Range 2.90 | +9.17% Year-to-Date |
| Previous close | 1.29 |
| Today’s open | 1.30 |
| Day’s range | 1.30 - 1.38 |
| Volume | 61,967 |
| Average volume (3 months) | 194,327 |
| Market cap | $54.3M |
| Earnings growth (last year) | -46.47% |
| Earnings growth (this year) | +32.91% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | 0.7 |
| Price/Sales | -- |
| Price/Book | 0.44 |
| Today’s change | Today’s % change | |
|---|---|---|
| AQXPAquinox Pharmaceutic... | -0.05 | -2.09% |
| ZSANZosano Pharma Corp | +0.05 | +1.63% |
| DMACDiaMedica Therapeuti... | -0.30 | -6.07% |
| OPNTOpiant Pharmaceutica... | +0.29 | +2.12% |
| Next reporting date | August 5, 2019 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | $63.1M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Glenn P. Sblendorio |
Chief Operating Officer & Senior Vice President Keith Westby |
Corporate headquarters New York, New York |
